0001144204-17-046887.txt : 20170906 0001144204-17-046887.hdr.sgml : 20170906 20170906192655 ACCESSION NUMBER: 0001144204-17-046887 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170313 FILED AS OF DATE: 20170906 DATE AS OF CHANGE: 20170906 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Reines Scott CENTRAL INDEX KEY: 0001716401 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38114 FILM NUMBER: 171072485 MAIL ADDRESS: STREET 1: 2 GANSEVOORT STREET, 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AVENUE THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001644963 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 474113275 STATE OF INCORPORATION: DE FISCAL YEAR END: 0430 BUSINESS ADDRESS: STREET 1: 2 GANSEVOORT STREET STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 BUSINESS PHONE: 781-652-4500 MAIL ADDRESS: STREET 1: 2 GANSEVOORT STREET STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 3 1 v474755_form3.xml FORM 3 X0206 3 2017-03-13 0 0001644963 AVENUE THERAPEUTICS, INC. ATXI 0001716401 Reines Scott C/O AVENUE THERAPEUTICS, INC. 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 0 1 0 0 Interim Chief Medical Officer Common Stock 35000 D The 35,000 shares of restricted Common Stock will vest as follows: One-fourth on August 8, 2018, one-fourth on August 8, 2019, one-fourth on August 8, 2020 and one-fourth on August 8, 2021. /s/ Lucy Lu, M.D., Attorney-in-Fact 2017-09-06